MedTrace Logo

Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy

NCT03299036 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-10-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of Radiopaque Microsphere (T-ACE Beads with doxorubicin) interventional therapy for patients with liver cancer

Conditions

  • Cancer of Liver

Interventions

DEVICE

Taiwan ACE Beads with doxorubicin

Similar with commercializing drug-eluting beads, radiologist inject Taiwan ACE Beads with doxorubicin instead of Gelfoam or polyvinyl alcohol.

Sponsors & Collaborators

  • The Industrial Technology Research Institute

    collaborator OTHER

  • National Cheng Kung University

    collaborator OTHER

  • National Cheng-Kung University Hospital

    lead OTHER

Principal Investigators

  • Xi-Zhang Lin · Department of Internal Medicine, National Cheng Kung University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2018-10-16
Completion
2018-10-16

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03299036 on ClinicalTrials.gov